Compare KRYS & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRYS | CIGI |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 7.3B |
| IPO Year | 2017 | N/A |
| Metric | KRYS | CIGI |
|---|---|---|
| Price | $241.84 | $146.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $214.22 | $175.00 |
| AVG Volume (30 Days) | ★ 286.6K | 124.9K |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 0.21% |
| EPS Growth | ★ 275.72 | N/A |
| EPS | ★ 6.66 | 2.30 |
| Revenue | $373,164,000.00 | ★ $5,453,534,000.00 |
| Revenue This Year | $36.14 | $17.67 |
| Revenue Next Year | $41.80 | $7.35 |
| P/E Ratio | ★ $36.72 | $63.26 |
| Revenue Growth | ★ 54.51 | 19.71 |
| 52 Week Low | $122.80 | $100.86 |
| 52 Week High | $248.60 | $171.51 |
| Indicator | KRYS | CIGI |
|---|---|---|
| Relative Strength Index (RSI) | 74.92 | 51.74 |
| Support Level | $213.83 | $142.99 |
| Resistance Level | $248.60 | $147.18 |
| Average True Range (ATR) | 7.44 | 3.09 |
| MACD | 1.29 | 0.96 |
| Stochastic Oscillator | 78.92 | 91.83 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.